
|Articles|July 16, 2021
- Vol 38, Issue 7
Two Crises I Didn’t Train For
Author(s)Richard M. Berlin, MD
"I can still hear my patient shriek..."
Advertisement
POETRY OF THE TIMES
Telepsychiatry makes it easier for psychiatrists to treat patients by eliminating the need for either party to travel, with services provided from the safety and comfort of the psychiatrist’s home.
- a Telepsych website
I can still hear my patient shriek
when a black bear appeared on camera
behind me, circled the rose garden sundial,
and reared up to study one small human
shielded only by a sunroom screen,
three hundred feral pounds of muscle
and claw, almost as frightening
as a virus a tenth of a micron wide.
Dr Berlin has been writing a poem about his experience of being a doctor every month for the past 23 years in Psychiatric TimesTM in a column called “Poetry of the Times.” He is instructor in psychiatry, University of Massachusetts Medical School, Worcester, Massachusetts. ❒
Articles in this issue
over 5 years ago
What Is Resilience?over 5 years ago
Is Epstein-Barr Virus to Blame for Cognition in Schizophrenia?over 5 years ago
Faith Communities and the Well-Being of LGBTQ Youthover 5 years ago
Shining a Spotlight on Bright Light for Acute Bipolar Depressionover 5 years ago
Addressing Apathy in Dementiaover 5 years ago
The Rise in Synthetic Cannabinoids and Cathinonesover 5 years ago
Perfecting the TrifectaAdvertisement
Related to this article

Phase 2 trial shows daridorexant boosts pediatric insomnia sleep time up to 50 minutes, including ADHD/ASD patients, with strong safety and phase 3 plans.

New automated connectomics maps synapses across circuits, revealing how inhibitory neuron subtypes shape decision-making and may explain circuit dysfunction in psychiatric disorders.

FDA aligns with Cognition on a phase 3 zervimesine trial for Lewy body dementia, testing 100 mg daily for 9 months to target hallucinations.

Sleep disruption fuels Alzheimer risk via apnea, fragmentation, and inflammation; improving consolidated sleep, medication review, and sleep-specialist teamwork may protect cognition.

UK AD-SMART platform trial speeds Alzheimer disease treatment discovery by testing multiple repurposed drugs at once across NHS sites, aiming to protect memory and quality of life.

When an antidepressant seems to stop working, the patient’s deterioration is real. The explanation may be less certain.

The evidence points toward an overall protective effect in adult cohorts and no increase in completed suicide in younger populations.
Advertisement
Advertisement
Trending on Psychiatric Times
1
MDD Side Effect Profiles: Counseling, Adherence, and Suicidality Monitoring
2
Synapse-Level Mapping Could Reveal How Disrupted Brain Circuits Lead to Psychiatric Disorders
3
Daridorexant, Orexin Receptor Agonist, Shows Positive Results in Pediatric Insomnia
4
Sleep Disruption and Alzheimer Disease: A Bidirectional, Treatable Relationship
5

